Skip to main content

Table 1 Clinicopathological information of the 35 basal cell adenoma cases

From: Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study

Case No.

Sex

Origin

Size (mm)

TLE1 (luminal cell)

β-catenin (abluminal cell)

Ki67

Mitosis (/10HPF)

CTNNB1 mutation

Follow-up (Months)

1

F

P

11

++

3.4%

1/10

6

2

M

P

20

++

++

1.1%

1/10

+

6

3

F

P

10

+

++

1%

1/10

2

4

M

P

20

++

+

1.3%

0/10

+

6

5

F

P

16

++

++

1.1%

0/10

+

25

6

M

P

30

++

1.9%

1/10

32

7

F

P

30

++

- (cytoplasm+)

3%

1/10

38

8

F

P

20

++

++

0.5%

0/10

1

9

M

P

10

++

++

0.4%

1/10

38

10

M

P

20

++

+

1.1%

1/10

+

12

11

F

P

20

+

1.7%

0/10

43

12

M

P

20

++

++

1.5%

0/10

1

13

F

P

8

+

+

1.1%

1/10

28

14

F

P

35

1.0%

0/10

76

15

F

P

26

+

++

1.3%

0/10

18

16

M

S

44

+

0.9%

3/10

18

17

F

P

10

++

++

1.0%

1/10

+

141

18

F

P

15

+

+

2.3%

1/10

100

19

F

P

20

+

++

1.0%

1/10

7

20

F

P

60

+

+

2.4%

0/10

+

12

21

F

P

25

+

++

1.5%

0/10

+

65

22

M

P

20

- (old sample)

1.0%

0/10

+

43

23

F

S

10

++

1.7%

0/10

4

24

F

P

20

++

++

1.7%

0/10

+

1

25

M

P

50

++

3.8%

0/10

1

26

M

P

30

+

++

1.6%

1/10

1

27

F

P

16

++

++

2.5%

1/10

36

28

M

P

31

++

++

2.7%

1/10

2

29

M

P

17

+

++

1.2%

0/10

0.5

30

M

P

20

++

++

2.2%

1/10

0.5

31

M

P

31

++

++

2.3%

1/10

0.5

32

M

P

20

++

+

0.8%

1/10

+

NA

33

F

P

25

++

+

1.4%

1/10

+

36

34

F

P

23

++

++

1.8%

1/10

156

35

M

P

15

+

+

1.0%

1/10

+

2

  1. P parotid gland, S submandibular gland, HPF high power field, NA not available